Disclosures for "Prevalence of Neurocognitive Disorder in a Pre-manifest Huntington’s disease Cohort")
-
Mr. Sierra has nothing to disclose.
-
Miss Ullman has nothing to disclose.
-
Ms. Baselga-Garriga has nothing to disclose.
-
Miss Hildebrand has nothing to disclose.
-
Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Triplet Therapeutics.
-
Dr. Laganiere has received research support from HDSA.